CYP2D6 and paroxetine treatment of depressive disorder

HADAŠOVÁ, Eva and Alexandra ŽOURKOVÁ. CYP2D6 and paroxetine treatment of depressive disorder. In 18th European Workshop on Drug Metabolism, Abstract Book. Valencia (Španělsko): European Society of Biochemical Pharmacology, 2002, p. 52.

Basic information

Original name

CYP2D6 and paroxetine treatment of depressive disorder

Authors

HADAŠOVÁ, Eva (203 Czech Republic, guarantor) and Alexandra ŽOURKOVÁ (203 Czech Republic)

Edition

Valencia (Španělsko), 18th European Workshop on Drug Metabolism, Abstract Book, p. 52-52, 2002

Publisher

European Society of Biochemical Pharmacology

---

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Spain

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/02:00006538

Organization unit

Faculty of Medicine

Keywords in English

paroxetine-depressive disorder-CYP2D6

Tags

paroxetine-depressive disorder-CYP2D6

Tags

International impact, Reviewed

---

Abstract

V originále

The study includes clinical correlates of the paroxetine treatment with regard to the level of CYP2D6 inhibition.

---

Links

NF6159, research and development project

Name: Dynamika fenotypu CYP 2D6 u pacientů léčených paroxetinem ve vztahu ke klinickým korelátům. Investor: Ministry of Health of the CR, Phenotype dynamics in patient treated by paroxetine regarding the clinical correlates